Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Carina Hage

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5352-0742; OpenAlex author ID A5001247486. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Correction: The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer. Co-author DOI 10.1038/s41419-023-06385-9↗
  2. The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer. Co-author DOI 10.1038/cddis.2013.158↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Clifford C. Nwaeburu · 2 shared papers, 2013–2024 · strength 0.24
  2. Nathalia A. Giese · 2 shared papers, 2013–2024 · strength 0.24
  3. Ingrid Herr · 2 shared papers, 2013–2024 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.